Clover Health Investments (BOVESPA:CLOV34) - Hisse Senedi Fiyatı, Haberler ve Analizler

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

CLOV34 Stoklara Genel Bakış

Clover Health Investments, Corp. Amerika Birleşik Devletleri'nde medicare avantaj planları sağlamaktadır.

CLOV34 temel anali̇z
Kar Tanesi Skoru
Değerleme	1/6
Gelecekteki Büyüme	0/6
Geçmiş Performans	0/6
Finansal Sağlık	6/6
Temettüler	0/6

Ödüller

Kazançlar son 5 yılda yılda 2.6% oranında arttı

Risk Analizi

Son 3 ayda hisse senedi fiyatı oldukça dalgalıydı

Şu anda kârlı değil ve önümüzdeki 3 yıl içinde kârlı hale gelmesi beklenmiyor

Hissedarlar geçen yıl sulandırıldı

Clover Health Investments, Corp. Rakipler

Odontoprev

BOVESPA:ODPV3

R$5.9b

Hapvida Participações e Investimentos

BOVESPA:HAPV3

R$28.2b

Qualicorp Consultoria e Corretora de Seguros

BOVESPA:QUAL3

R$594.8m

Fleury

BOVESPA:FLRY3

R$8.1b

Fiyat Geçmişi ve Performans

için tüm zamanların en yüksek seviyelerinin, değişikliklerin ve fiyat düşüşlerinin özeti Clover Health Investments
Tarihsel hisse senedi fiyatları
Güncel Hisse Fiyatı	US$23.05
52 Haftanın En Yüksek Seviyesi	US$25.86
52 Haftanın En Düşük Seviyesi	US$3.19
Beta	2.14
11 Aylık Değişim	40.38%
3 Aylık Değişim	151.64%
1 Yıllık Değişim	363.78%
33 Yıllık Değişim	n/a
5 Yıllık Değişim	n/a
Halka arzdan bu yana değişim	94.68%

Son Haberler & Güncellemeler

Recent updates

Hissedar Getirileri

	CLOV34	BR Healthcare	BR Pazar
7D	-0.9%	-0.6%	0.7%
1Y	363.8%	0.7%	9.6%

Getiri vs. Endüstri: CLOV34 geçen yıl % -5.1 oranında getiri sağlayan BR Healthcare sektörünü aştı.

Getiri vs Piyasa: CLOV34 geçen yıl % 10.5 oranında getiri sağlayan BR Piyasasını aştı.

Fiyat Oynaklığı

Is CLOV34's price volatile compared to industry and market?
CLOV34 volatility
CLOV34 Average Weekly Movement	15.0%
Healthcare Industry Average Movement	6.4%
Market Average Movement	4.4%
10% most volatile stocks in BR Market	9.1%
10% least volatile stocks in BR Market	2.2%

İstikrarlı Hisse Senedi Fiyatı: CLOV34 hisse senedi fiyatı son 3 aydır dalgalı bir seyir izliyor.

Zaman İçindeki Volatilite: CLOV34 'nin haftalık oynaklığı ( 15% ) geçen yıl boyunca sabit kaldı, ancak hala BR hisselerinin %75'inden yüksek.

Şirket Hakkında

Kuruldu	Çalışanlar	CEO	Web sitesi
n/a	552	Andrew Toy	www.cloverhealth.com/en/

Clover Health Investments, Corp. Amerika Birleşik Devletleri'nde medicare avantaj planları sağlamaktadır. İki segment üzerinden faaliyet göstermektedir: Sigorta ve Sigorta Dışı. Ayrıca, doktorların kronik hastalıkları daha erken tespit etmelerini, tanımlamalarını ve yönetmelerini sağlayan bulut tabanlı bir yazılım platformu olan Clover Assistant'ı ve tedavi ettikleri hastalar için veri odaklı ve kişiselleştirilmiş içgörülere erişim sunmaktadır.

Clover Health Investments, Corp. Temel Bilgiler Özeti

Clover Health Investments'un kazançları ve gelirleri piyasa değeriyle nasıl karşılaştırılır?
CLOV34 temel i̇stati̇sti̇kler
Piyasa değeri	R$11.34b
Kazançlar(TTM)	-R$688.42m
Gelir(TTM)	R$11.91b

1.0x

P/S Oranı

-16.5x

F/K Oranı

CLOV34 aşırı değerli mi?

Gerçeğe Uygun Değer ve değerleme analizine bakınız

Kazanç ve Gelir

En son kazanç raporundan temel karlılık istatistikleri (TTM)
CLOV34 gelir tablosu (TTM)
Gelir	US$2.09b
Gelir Maliyeti	US$1.77b
Brüt Kâr	US$319.02m
Diğer Giderler	US$439.80m
Kazançlar	-US$120.77m

Son Raporlanan Kazançlar

Jun 30, 2024

Sonraki Kazanç Tarihi

n/a

Hisse başına kazanç (EPS)	-0.24
Brüt Marj	15.27%
Net Kâr Marjı	-5.78%
Borç/Özkaynak Oranı	0%

CLOV34 uzun vadede nasıl bir performans gösterdi?

Geçmiş performansı ve karşılaştırmayı görün

CLOV34 Stoklara Genel Bakış

Ödüller

Risk Analizi

Clover Health Investments, Corp. Rakipler

BOVESPA:ODPV3

R$5.9b

BOVESPA:HAPV3

R$28.2b

BOVESPA:QUAL3

R$594.8m

BOVESPA:FLRY3

R$8.1b

Fiyat Geçmişi ve Performans

Son Haberler & Güncellemeler

Clover Health Announces Debut of Its 2025 Medicare Advantage Plan Offerings in New Jersey

Clover Health Investments, Corp Appoints Joseph Brand as Chief Operating Officer for Medicare Advantage Operations

Clover Health Investments, Corp. Appoints Thomas L. Tran to Its Board of Directors and Member of the Audit Committee

Clover Health Investments, Corp. to Report Q2, 2024 Results on Aug 05, 2024

Clover Health Investments, Corp. Announces Counterpart Health, A New SaaS and Tech Enabled Services Solution to Bring the Power of CA Technology to All Medicare Advantage Payors and Providers

Clover Health Investments, Corp. (NasdaqGS:CLOV) announces an Equity Buyback for $20 million worth of its shares.

Recent updates

Clover Health Announces Debut of Its 2025 Medicare Advantage Plan Offerings in New Jersey

Clover Health Investments, Corp Appoints Joseph Brand as Chief Operating Officer for Medicare Advantage Operations

Clover Health Investments, Corp. Appoints Thomas L. Tran to Its Board of Directors and Member of the Audit Committee

Clover Health Investments, Corp. to Report Q2, 2024 Results on Aug 05, 2024

Clover Health Investments, Corp. Announces Counterpart Health, A New SaaS and Tech Enabled Services Solution to Bring the Power of CA Technology to All Medicare Advantage Payors and Providers

Clover Health Investments, Corp. (NasdaqGS:CLOV) announces an Equity Buyback for $20 million worth of its shares.

Clover Health Investments, Corp., Annual General Meeting, Jun 10, 2024

Clover Health Investments, Corp. to Report Q1, 2024 Results on May 07, 2024

Clover Health Investments, Corp. Announces the Appointment of Peter Kuipers as Chief Financial Officer

Clover Health Investments Receives Written Notice from The Nasdaq Stock Market LLC Regarding Non-Compliance with the Minimum Bid Price Requirement

Clover Health Investments, Corp. Reports Impairment of Goodwill and Other Intangible Assets for the Fourth Quarter Ended December 31, 2023

Clay Thornton Joins Clover Health as CFO of Medicare Advantage Division

Clover Health Investments, Corp. to Report Q4, 2023 Results on Mar 12, 2024

Clover Health Investments, Corp. Announces Management Changes

Clover Health Investments, Corp. Announces Resignation of Scott J. Leffler as Chief Financial Officer, Effective January 26, 2024

Clover Health Investments, Corp. Updates Earnings Guidance for the Full Year 2023

Clover Health Promotes Karen Soares to General Counsel

Clover Health Investments, Corp. to Report Q3, 2023 Results on Nov 06, 2023

Clover Health Investments, Corp. Provides Earnings Guidance for the Year 2023

Clover Health Regains Compliance with NASDAQ Minimum Bid Price Requirement

Clover Health Investments, Corp. to Report Q2, 2023 Results on Aug 08, 2023

Clover Health Investments, Corp. Announces Agreement to Settle Derivative Litigation, Resolving All Remaining Civil Litigation Relating to its de-SPAC Transaction

Clover Health Investments, Corp. Announces the Resignation of Joseph Martin as General Counsel and Corporate Secretary

Clover Health Investments, Corp. Provides Revenue Guidance for the Full Year 2023

Clover Health Investments, Corp., Annual General Meeting, Feb 07, 2023

Clover Health Investments, Corp. to Report Q4, 2022 Results on Feb 28, 2023

Clover Health Investments, Corp. Announces Stepdown of Prabhdeep Singh as Chief Growth Officer, Effective March 31, 2023

Clover Health Investments, Corp. Appoints Jamie L. Reynoso as Chief Executive Officer of Medicare Advantage

Clover Health Investments, Corp. Announces the Appointment of Anna Loengard, M.D. to the Company’s Board of Directors

Clover Health Investments, Corp. Provides Earnings Guidance for the Year 2022

Clover Health Investments, Corp. to Report Q3, 2022 Results on Nov 07, 2022

Clover Health Investments, Corp., Annual General Meeting, Sep 22, 2022

Clover Health Investments, Corp. Announces CEO Changes, Effective January 1, 2023

Clover Health Investments, Corp. Appoints Scott J. Leffler as its Chief Financial Officer

Clover Health Investments, Corp. Announces Appointment of Carladenise Armbrister Edwards to Board of Directors

Clover Health Investments, Corp. to Report Q2, 2022 Results on Aug 08, 2022

Clover Health Investments, Corp. Announces Resignation of Nathaniel S. Turner as Member of the Board of Directors

Clover Health Appoints Scott J. Leffler as Chief Financial Officer

Clover Health Investments, Corp. Reaffirms Revenue Guidance for the Full Year 2022

Clover Health Investments, Corp. to Report Q1, 2022 Results on May 09, 2022